Design and analysis of partially randomized preference trials with propensity score stratification

被引:4
作者
Wang, Yumin [1 ]
Li, Fan [1 ]
Blaha, Ondrej [1 ]
Meng, Can [1 ]
Esserman, Denise [1 ]
机构
[1] Yale Sch Publ Hlth, Dept Biostat, 300 George St,Suite 511, New Haven, CT 06511 USA
基金
美国国家卫生研究院;
关键词
Patient preference; partially randomized preference design; propensity score; sample size; power; stratified design; VISUAL ANALOG SCALE; HIV; IMPLEMENTATION; TUBERCULOSIS; SENSITIVITY; HEPATITIS;
D O I
10.1177/09622802221095673
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
While the two-stage randomized design allows us to unbiasedly evaluate the impact of patients' treatment preference on the outcome of interest, it may not always be practical to implement in clinical practice; patients with a strong preference may not be willing to be randomized. The more pragmatic, partially randomized preference design (PRPD) allows patients who are unwilling to be randomized, but willing to state their preference, to receive their preferred treatment in lieu of the first-stage randomization in the two-stage design, at the cost of potentially introducing bias in estimating the effects of interest. In this article, we consider the application of propensity score stratification (PSS) in a PRPD to recreate a conditional first-stage randomization based on observed covariates, enabling the estimation and inference of the overall treatment, selection and preference effects with minimum bias. We additionally derive a set of closed-form sample size formulas for detecting all three effects of interest in a PSS-PRPD. Simulation studies demonstrate the bias reduction properties of the PSS-PRPD, and validate the accuracy of the proposed sample size formulas. Our results show that 5 to 10 propensity score strata may be needed to correct for biases in effect estimates, and the exact number of strata needed to achieve the best match between the empirical power and formula prediction may depend on the degree of effect heterogeneity. Finally, we demonstrate our proposed formulas by estimating the required sample sizes to detect treatment, selection and preference effects in the context of the Harapan Study.
引用
收藏
页码:1515 / 1537
页数:23
相关论文
共 39 条
[11]   Evaluating preference effects in partially unblinded, randomized clinical trials [J].
Halpern, SD .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (02) :109-115
[12]   Estimating heterogeneous survival treatment effect in observational data using machine learning [J].
Hu, Liangyuan ;
Ji, Jiayi ;
Li, Fan .
STATISTICS IN MEDICINE, 2021, 40 (21) :4691-4713
[13]  
Kahrilas PJ., SEM GASTR DIS, V12, P3
[14]   THE VISUAL ANALOG SCALE - ITS USE IN PAIN MEASUREMENT [J].
LANGLEY, GB ;
SHEPPEARD, H .
RHEUMATOLOGY INTERNATIONAL, 1985, 5 (04) :145-148
[15]   A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care? [J].
Larney, Sarah ;
Dolan, Kate .
EUROPEAN ADDICTION RESEARCH, 2009, 15 (02) :107-112
[16]   Improving propensity score weighting using machine learning [J].
Lee, Brian K. ;
Lessler, Justin ;
Stuart, Elizabeth A. .
STATISTICS IN MEDICINE, 2010, 29 (03) :337-346
[17]   Addressing Extreme Propensity Scores via the Overlap Weights [J].
Li, Fan ;
Thomas, Laine E. ;
Li, Fan .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2019, 188 (01) :250-257
[18]   Balancing Covariates via Propensity Score Weighting [J].
Li, Fan ;
Morgan, Kari Lock ;
Zaslavsky, Alan M. .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2018, 113 (521) :390-400
[19]   Assessing the sensitivity of regression results to unmeasured confounders in observational studies [J].
Lin, DY ;
Psaty, BM ;
Kronmal, RA .
BIOMETRICS, 1998, 54 (03) :948-963
[20]   Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study [J].
Lunceford, JK ;
Davidian, M .
STATISTICS IN MEDICINE, 2004, 23 (19) :2937-2960